Gene therapy for children with sickle cell disease approved by FDA
A new treatment for children aged 2 or older with sickle cell disease has been approved by the U.S. Food & Drug Administration.
A new treatment for children aged 2 or older with sickle cell disease has been approved by the U.S. Food & Drug Administration.
Summary aggregated from The Hill's public RSS feed. The full reporting belongs to The Hill — please read it on their site.